VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 134 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $23,000 | -77.5% | 2,186 | -64.7% | 0.01% | -40.0% |
| Q4 2019 | $102,000 | +32.5% | 6,197 | +6.9% | 0.02% | 0.0% |
| Q3 2019 | $77,000 | +71.1% | 5,797 | +81.2% | 0.02% | +53.8% |
| Q2 2019 | $45,000 | -81.6% | 3,199 | -75.4% | 0.01% | -60.6% |
| Q1 2019 | $244,000 | +419.1% | 13,000 | +538.8% | 0.03% | +266.7% |
| Q3 2018 | $47,000 | -79.3% | 2,035 | -82.8% | 0.01% | -82.7% |
| Q2 2018 | $227,000 | +122.5% | 11,835 | +92.9% | 0.05% | +108.0% |
| Q1 2018 | $102,000 | -12.8% | 6,135 | -20.4% | 0.02% | -7.4% |
| Q4 2017 | $117,000 | -4.1% | 7,703 | +13.2% | 0.03% | 0.0% |
| Q3 2017 | $122,000 | -62.8% | 6,803 | -66.2% | 0.03% | -43.8% |
| Q2 2017 | $328,000 | -42.2% | 20,103 | -50.4% | 0.05% | -26.2% |
| Q1 2017 | $567,000 | +141.3% | 40,503 | +175.5% | 0.06% | +116.7% |
| Q4 2016 | $235,000 | -28.4% | 14,703 | -25.4% | 0.03% | -28.6% |
| Q3 2016 | $328,000 | +375.4% | 19,700 | +217.7% | 0.04% | +320.0% |
| Q2 2016 | $69,000 | – | 6,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 728,000 | $10,425,000 | 5.01% |
| Signpost Capital Advisors, LP | 828,793 | $11,868,000 | 4.38% |
| Palo Alto Investors LP | 3,786,908 | $54,229,000 | 3.18% |
| RTW INVESTMENTS, LP | 500,000 | $7,160,000 | 2.65% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,139,787 | $59,282,000 | 2.13% |
| First Light Asset Management, LLC | 229,818 | $3,291,000 | 1.86% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,461,305 | $35,246,000 | 1.53% |
| PURA VIDA INVESTMENTS, LLC | 175,000 | $2,506,000 | 0.92% |
| WALL STREET ASSOCIATES | 655,800 | $9,391,000 | 0.90% |
| SPHERA FUNDS MANAGEMENT LTD. | 368,390 | $5,275,000 | 0.90% |